Two nosocomial pertussis outbreaks and their associated costs - King County, Washington, 2004

Infection Control and Hospital Epidemiology

Volumn 28, Issue 5, 2007, Pages 537-543

  Baggett, Henry C ^a,e,g   Duchin, Jeffrey S ^a,b   Shelton, William ^c   Zerr, Danielle M ^b,d   Heath, Joan ^d   Ortega Sanchez, Ismael R ^f   Tiwari, Tejpratap ^f  

^a Epidemiology   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^g Centers for Disease Control CDC Thailand Field Station   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; PERTUSSIS; UNITED STATES;

ADULT; BORDETELLA PERTUSSIS; CONTACT TRACING; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HEALTH PERSONNEL; HOSPITAL COSTS; HOSPITALS, GENERAL; HOSPITALS, PEDIATRIC; HUMANS; INFECTION CONTROL; INTERVIEWS; ORGANIZATIONAL CASE STUDIES; POLYMERASE CHAIN REACTION; PREGNANCY; WASHINGTON; WHOOPING COUGH;

EID: 34249275638     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/513497     Document Type: Article

References (19)

1. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy T. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003; 290:2968-2975.
2. De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Douville FM. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174-179.
3. Edwards KE, Decker MD. Pertussis vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia, PA: WB Saunders, 2004:471-528.
4. Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other control measures: recommendations of the Immunization Practices Advisory committee (ACIP). MMWR Morb Mort Wkly Rep 1991; 40(RR-10):1-28.
5. Tablan OC, Anderson LJ, Besser R, Bridges C, Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Morb Mort Wkly Rep 2004; 53(RR-3):1-36.
6. Centers for Disease Control and Prevention. Guidelines for the control of pertussis outbreaks. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2006. Available at: http://www.cdc.gov/nip/publications/pertussis/guide.htm. Accessed on March 20, 2006.
7. Ward A, Caro J, Bassinet L, Housset B, O'Brien JA, Guiso N. Health and economic consequences of an outbreak of pertussis among health-care workers in a hospital in France. Infect Control Hosp Epidemiol 2005; 26:288-292.
8. Calugar A, Ortega-Sanchez I, Tiwari T, Oakes L, Jahre JA, Murphy T. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006; 42: 981-988.
9. Christie CD, Glover AM, Willke MJ, Marx ML, Reising SF, Hutchinson NM. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995; 16:556-563.
10. Zivna I, Bergin D, Casavant J, et al. Bordetella pertussis exposure in a Massachusetts tertiary care medical system, FY 2004 [abstract 191]. In: Program and abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Los Angeles, California): 108.
11. Council of State and Territorial Epidemiologists (CSTE). 1997 Position Statements. CSTE National Meeting, Saratoga Springs, NY: CSTE. Position statement 9. Available at: http://www.cste.org/ps/1997/1997-id -09.htm. Accessed on March 20, 2006.
12. Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997; 35:2435-2443.
13. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988; 296: 612-614.
14. He Q, Viljanen MK, Nikkari S, Lyytikainen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994; 170:873-877.
15. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273:1044-1046.
16. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-1674.
17. Bolyard EA , Talban OC, Williams WW, Pearson ML, Shapiro CN, Deitchman SD, and The Hospital Infection Control Practices Advisory Committee. Guideline for infection control in health care personnel, 1998. Infect Control Hosp Epidemiol 1998; 19:407-463.
18. Tiwari T, Murphy TV, Moran J; National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54:1-16.
19. Centers for Disease Control and Prevention. ACIP votes to recommend use of combined tetanus, diphtheria and pertussis (Tdap) vaccine for adults (Updated March 3, 2006). Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ nip/vaccine/tdap/tdap_adult_recs.pdf. Accessed on March 20, 2006.